Skip to main content

STANDARD BIOTOOLS INC. (LAB) Stock Forecast 2025 - AI Price Prediction & Analysis


STANDARD BIOTOOLS INC. (LAB) AI Stock Price Forecast & Investment Analysis

STANDARD BIOTOOLS INC. Stock Price Chart and Technical Analysis

Loading STANDARD BIOTOOLS INC. interactive price chart and technical analysis...

STANDARD BIOTOOLS INC. (LAB) - Comprehensive Stock Analysis & Investment Research

Deep dive into STANDARD BIOTOOLS INC.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about STANDARD BIOTOOLS INC., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For STANDARD BIOTOOLS INC.: STANDARD BIOTOOLS INC. operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

STANDARD BIOTOOLS INC. (Stock Symbol: LAB) is a leading company in the Industrial Applications and Services sector , specifically operating within the Laboratory Analytical Instruments industry.

The organization employs approximately 457 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing STANDARD BIOTOOLS INC.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For STANDARD BIOTOOLS INC.: With $133M in annual revenue and -268.2% net margin, the company demonstrates developing profitability.

Annual Revenue: $133 million generating a -268.2% net profit margin .

Market Capitalization: $485 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -160.9% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for STANDARD BIOTOOLS INC. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For STANDARD BIOTOOLS INC.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for STANDARD BIOTOOLS INC. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: STANDARD BIOTOOLS INC.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For STANDARD BIOTOOLS INC.: Market positioning analysis based on available financial and operational metrics.

STANDARD BIOTOOLS INC. strategically competes in the highly dynamic Laboratory Analytical Instruments marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 291.2% gross margin, indicating strong pricing power and operational efficiency.

STANDARD BIOTOOLS INC. (LAB) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for STANDARD BIOTOOLS INC. stock analysis.

Loading STANDARD BIOTOOLS INC. comprehensive fundamental analysis and insider trading data...

Deep dive into STANDARD BIOTOOLS INC.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if STANDARD BIOTOOLS INC. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For STANDARD BIOTOOLS INC.: With a P/E ratio of -2.36, the market sees the stock as potentially undervalued.

P/E Ratio -2.36x
P/B Ratio 1.14x
Market Cap $485M
EPS $-0.31
Book Value/Share $1.11
Revenue/Share $0.35
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently STANDARD BIOTOOLS INC. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For STANDARD BIOTOOLS INC.: An ROE of -160.9% indicates room for improvement in shareholder value creation.

ROE -160.9%
ROA -40.4%
ROIC -59.5%
Gross Margin 291.2%
Operating Margin -648.8%
Net Margin -268.2%
EBT Margin -96.6%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess STANDARD BIOTOOLS INC.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For STANDARD BIOTOOLS INC.: A current ratio of 1.55 shows adequate liquidity.

Current Ratio 1.55x
Quick Ratio 0.96x
D/E Ratio 6.18x
Financial Leverage 12.30x
Interest Coverage -29.3x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal STANDARD BIOTOOLS INC.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For STANDARD BIOTOOLS INC.: Free cash flow of $-54M indicates cash challenges that need attention.

Operating Cash Flow $-47M
Free Cash Flow $-54M
Capital Spending $-7M
FCF/Sales -43.4%
CapEx/Sales 5.8%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively STANDARD BIOTOOLS INC. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For STANDARD BIOTOOLS INC.: An asset turnover of 0.43x suggests room for improvement in asset utilization.

Asset Turnover 0.43x
Receivables Turnover 8.1x
Inventory Turnover 2.7x
Fixed Assets Turnover 2.0x
Days Sales Outstanding 45 days
Days Inventory 133 days
Payables Period 74 days
Cash Conversion Cycle 105 days
Understanding Financial Statement Data

What these metrics mean: Key figures from STANDARD BIOTOOLS INC.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For STANDARD BIOTOOLS INC.: With annual revenue of $133M, STANDARD BIOTOOLS INC. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $133M
R&D Expense $55M
SG&A Expense $82M
Cost of Goods Sold $80M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 27%
Cash & Short-term Investments 11%
Total Liabilities 92%
Short-term Debt 2%
Accounts Receivable 6%
Inventory 9%
Dividend & Shareholder Information
Shares Outstanding 382M
Growth Metrics (YoY)
EPS Growth -49.7%

Latest STANDARD BIOTOOLS INC. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting STANDARD BIOTOOLS INC. (LAB) stock price and investment outlook.

📰 We are currently updating our news feed for STANDARD BIOTOOLS INC.. Check back soon for the latest market analysis and company updates.

STANDARD BIOTOOLS INC. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of STANDARD BIOTOOLS INC. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
A Unlock Forecast - 30 Days FREE Trial $39604M 32.5x 6.2x
ASTC Unlock Forecast - 30 Days FREE Trial $7M 28.9x 0.3x
AVTR Unlock Forecast - 30 Days FREE Trial $9931M 14.5x 1.6x
BIO Unlock Forecast - 30 Days FREE Trial $8619M 27.0x 1.2x
BIO-B Unlock Forecast - 30 Days FREE Trial $7860M 24.6x 1.1x
BNGO Unlock Forecast - 30 Days FREE Trial $7M 0.0x 0.2x
BRKR Unlock Forecast - 30 Days FREE Trial $5796M 72.8x 3.3x
CTKB Unlock Forecast - 30 Days FREE Trial $502M 82.0x 1.3x
EYPT Unlock Forecast - 30 Days FREE Trial $792M -4.4x 3.2x
HBIO Unlock Forecast - 30 Days FREE Trial $17M -8.3x 1.1x
ILMN Unlock Forecast - 30 Days FREE Trial $15154M 12.1x 6.7x
LAB Unlock Forecast - 30 Days FREE Trial $485M -2.4x 1.1x
LCTC Unlock Forecast - 30 Days FREE Trial $9M x 1.5x
NAUT Unlock Forecast - 30 Days FREE Trial $123M -3.8x 0.7x
PACB Unlock Forecast - 30 Days FREE Trial $493M -1.5x 8.0x
PRPO Unlock Forecast - 30 Days FREE Trial $26M -1.2x 1.8x
RPID Unlock Forecast - 30 Days FREE Trial $137M -0.9x 2.5x
RVTY Unlock Forecast - 30 Days FREE Trial $10935M 38.3x 1.5x
SEER Unlock Forecast - 30 Days FREE Trial $137M -2.0x 0.4x
TXG Unlock Forecast - 30 Days FREE Trial $1538M -8.6x 2.0x
WAT Unlock Forecast - 30 Days FREE Trial $19929M 30.1x 9.2x

Frequently Asked Questions - STANDARD BIOTOOLS INC. Stock Forecast

How accurate are STANDARD BIOTOOLS INC. stock predictions?

Our AI model demonstrates 51% historical accuracy for LAB predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence STANDARD BIOTOOLS INC. stock price forecasts?

Our analysis considers STANDARD BIOTOOLS INC.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is STANDARD BIOTOOLS INC. a good investment in 2025?

Based on our AI analysis, STANDARD BIOTOOLS INC. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are STANDARD BIOTOOLS INC. forecasts updated?

STANDARD BIOTOOLS INC. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced STANDARD BIOTOOLS INC. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for STANDARD BIOTOOLS INC. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...